Activist & passive stakes

Investors crossing the 5% ownership line, from SEC Schedule 13D (activist) and 13G (passive) filings. Newest first.

Showing the last 10 days.Sign up free for 90 days
Amendments only.1–16 of 16
  • ActivistAmendment 6
    Nov 12, 2026
    OFIX · Orthofix Medical Inc.
    Juniper Investment Company, LLC
    13.4% · 5,481,846 shSEC
  • PassiveAmendment 9
    Nov 12, 2026
    THO · Thor Inds Inc
    Kayne Anderson Rudnick Investment Management, LLC
    5.2% · 2,690,130 shSEC
  • PassiveAmendment 3
    Nov 12, 2026
    PTHS · Pelthos Therapeutics Inc.
    3i, LP
    9.9% · 383,447 shSEC
  • PassiveAmendment 1Below 5%
    Nov 12, 2026
    AUTL · Autolus Therapeutics PLC
    Qatar Investment Authority
    3.5% · 9,184,404 shSEC
  • PassiveAmendment 5Below 5%
    Nov 10, 2026
    PHAT · Phathom Pharmaceuticals Inc
    Invesco Ltd.
    0% · 30,562 shSEC
  • ActivistAmendment 40
    Nov 10, 2026
    HERZ · Herzfeld Credit Income Fund, Inc.
    Thomas J. Herzfeld, et al.
    38.16% · 733,098 shSEC
  • PassiveAmendment 4
    Nov 10, 2026
    BCDA · BioCardia, Inc.
    Thomas A. Satterfield, Jr.
    9.9% · 1,539,134 shSEC
  • PassiveAmendment 4
    Nov 10, 2026
    CRIS · Curis, Inc.
    Thomas A. Satterfield, Jr.
    8.8% · 616,565 shSEC
  • PassiveAmendment 1Below 5%
    Nov 10, 2026
    NVNO · enVVeno Medical Corporation
    Thomas A. Satterfield, Jr.
    4.8% · 33,470 shSEC
  • PassiveAmendment 3
    Nov 10, 2026
    OSTX · OS Therapies Incorporated
    Thomas A. Satterfield, Jr.
    9.9% · 5,434,150 shSEC
  • ActivistAmendment 3
    Nov 9, 2026
    NABL · N-able, Inc.
    Thoma Bravo UGP, LLC
    28.3% · 50,090,643 shSEC
  • ActivistAmendment 5
    Nov 7, 2026
    SVIA · Silvia, Inc.
    Anthony Pompliano
    20% · 15,101,020 shSEC
  • ActivistAmendment 1
    Nov 6, 2026
    HCA · HCA Healthcare, Inc.
    Thomas F. Frist, Jr.
    33.8% · 70,536,810 shSEC
  • PassiveAmendment 2Below 5%
    Nov 6, 2026
    LIFE · Ethos Technologies Inc.
    Gv 2021, L.P.
    1.8% · 571,907 shSEC
  • ActivistAmendment 2
    Nov 4, 2026
    PTHS · Pelthos Therapeutics Inc.
    Ligand Pharmaceuticals Incorporated
    49.9% · 5,189,177 shSEC
  • ActivistAmendment 8
    Nov 3, 2026
    PRTH · Priority Technology Holdings, Inc.
    Thomas C. Priore
    56.4% · 46,600,996 shSEC